Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1980 record(s)

Req # A-2021-001743

Adverse Drug Reactions (ADRs). Report numbers: 000967789, 000967793, 000967796.

Organization: Health Canada

22 page(s)
January 2022

Req # A-2015-000243

All records contained in or referenced in all Natural and Non-prescription Health Products Directorate (NHPD) master files referred to by Cambrian Solutions with respect to chicken eggshell membrane, or partially hydrolyzed chicken eggshell membranes, including MF 40396-MF003.

Organization: Health Canada

268 page(s)
January 2022

Req # A-2016-000167

The clinical and quality evaluation reports/reviews from Health Canada during 1983 - 1996 inclusive for the following product: LUPRON DEPOT (leuprolide acetate) by TAP Pharmaceuticals Inc and any and all of their subsidies and affiliates.

Organization: Health Canada

1282 page(s)
January 2022

Req # A-2016-000241

All documents between Health Canada and the sponsor regarding section 2.3, 2.5, and 2.7 of the Abbreviated New Drug Submissions(s) (ANDS) and Notice(s) of Compliance for SANDOZ TACROLIMUS.

Organization: Health Canada

1032 page(s)
January 2022

Req # A-2020-000771

The Medical Device License Application Form that resulted in the first issuance of a Medical Device Licence for the LAP-BAND ADJUSTABLE GASTRIC BANDING (LAGB) SYSTEM (License No. 12197) medical device; the device first issuance date being September 20, 1999.

Organization: Health Canada

19 page(s)
January 2022

Req # A-2020-000790

The name of every manufacturer of the LAP-BAND ADJUSTABLE GASTRIC BANDING (LAGB) SYSTEM (License No. 12197) medical device since the device first issuance date, that being September 20, 1999.

Organization: Health Canada

26 page(s)
January 2022

Req # A-2020-000791

Every Medical Device License of the LAP-BAND ADJUSTABLE GASTRIC BANDING (LAGB) SYSTEM (License No. 12197) medical device since the device first issuance date, that being September 20, 1999.

Organization: Health Canada

75 page(s)
January 2022

Req # A-2020-001047

The total number of medical abortions (mifepristone and misoprostol) dispensed in Canada since the drug became legal in 2017. Any reports of adverse affects attributed to these medical abortions in Canada since the drug became legal in 2017.

Organization: Health Canada

195 page(s)
January 2022

Req # A-2020-001087

All briefing materials and summaries of correspondence between federal and provincial officials evaluating the COVID Alert app, including plans for its launch and discussion of its purpose and anticipated effectiveness, between July 31, 2020 to November 10, 2020.

Organization: Health Canada

1495 page(s)
January 2022

Req # A-2020-001161

All ProServices contracts issued in the National Capital Region for the months of July 2020, August 2020 & September 2020.

Organization: Health Canada

275 page(s)
January 2022
Date modified: